The development of antibody-drug conjugates (ADCs) and other bioconjugates requires sophisticated chemistry — from cytotoxic payload design to scalable synthesis and manufacturing. Abzena’s integrated chemistry services support the full ADC lifecycle, offering custom synthesis, chiral chemistry, linker-payload design, and proprietary ThioBridge™ conjugation technology to enhance stability and performance.
With deep expertise in handling highly potent compounds and scaling complex syntheses up to GMP production, Abzena ensures that even the most challenging molecular constructs progress smoothly from discovery to commercialisation.
Download the white paper here to learn how Abzena’s complex chemistry capabilities can accelerate your ADC development.
